Assessing Cardiac Safety in Oncology Drug Development

Based on a Cardiac Safety Research Consortium Think Tank held in October 2017 on “Detection, Assessment, and Risk Mitigation of Cardiac Safety Signals in Oncology Drug Development, this publication discusses emerging cardio-oncology nuances and the latest regulatory thinking on ways to manage risks. 

Previous Post
De-risking Clinical Trials Through Analytic Supported, On-Demand Medical Expertise From The World’s Leading Clinical Trial Experts
De-risking Clinical Trials Through Analytic Supported, On-Demand Medical Expertise From The World’s Leading Clinical Trial Experts

Next Video
Eliminating the Headache of Global Safety Reporting to Investigators and Ethics Committees
Eliminating the Headache of Global Safety Reporting to Investigators and Ethics Committees

New Blog: "Ask the IRB Experts"

Visit Blog